Health-related quality of life around the time of diagnosis in patients with bladder cancer

被引:20
作者
Yu, Evan Yi-Wen [1 ,2 ]
Nekeman, Duncan [3 ]
Billingham, Lucinda J. [4 ]
James, Nicholas D. [5 ]
Cheng, K. K. [3 ]
Bryan, Richard T. [5 ]
Wesselius, Anke [1 ]
Zeegers, Maurice P. [2 ]
机构
[1] Univ Maastricht, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands
[2] Univ Maastricht, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands
[3] Univ Birmingham, Sch Hlth & Populat Sci, Dept Publ Hlth Epidemiol & Biostat, Birmingham, W Midlands, England
[4] Univ Birmingham, MRC Midland Hub Trials Methodol Res & Canc Res UK, Birmingham, W Midlands, England
[5] Univ Birmingham, Sch Canc Sci, Birmingham, W Midlands, England
关键词
quality of life; time of diagnosis; cohort study; QLQ-C30; questionnaire; #BladderCancer; #blcsm; EUROPEAN-ORGANIZATION; UROTHELIAL CARCINOMA; EORTC QLQ-C30; STAGE; IMPACT; QUESTIONNAIRE; PROGRESSION; ASSOCIATION; RECURRENCE; RISK;
D O I
10.1111/bju.14804
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives To quantify the health-related quality of life (HRQoL) of patients with bladder cancer around the time of diagnosis and to test the hypotheses of a two-factor model for the HRQoL questionnaire QLQ-C30. Methods From participants in the Bladder Cancer Prognoses Programme, a multicentre cohort study, sociodemographic data were collected using semi-structured face-to-face interviews. Answers to the QLQ-C30 were transformed into a scale from 0 to 100. HRQoL data were analysed in multivariate analyses. The hypothesized two-factor (Physical and Mental Health) domain structure of the QLQ-C30 was also tested with confirmatory factor analyses (CFA). Results A total of 1160 participants (78%) completed the questionnaire after initial visual diagnosis and before pathological confirmation. Despite non-muscle-invasive bladder cancer (NMIBC) being associated with a higher HRQoL than carcinoma invading bladder muscle, only the domain Role Functioning was clinically significantly better in patients with NMIBC. Age, gender, bladder cancer stage and comorbidity all had a significant influence on QLQ-C30 scores. The CFA showed an overall good fit of the hypothesized two-factor model. Conclusion This study identified a baseline reference value for HRQoL for patients with bladder cancer, which allows better evaluation of any changes in HRQoL as disease progresses or after treatment. In addition, a two-factor (Physical and Mental Health) model was developed for the QLQ-C30.
引用
收藏
页码:984 / 991
页数:8
相关论文
共 59 条
[41]  
Scott NW, 2008, EORTC QLQ-C30 Reference Values Manual
[42]   Prospective evaluation of quality of life in patients with oral and oropharyngeal cancer: from diagnosis to three months post-treatment [J].
Shepherd, KL ;
Fisher, SE .
ORAL ONCOLOGY, 2004, 40 (07) :751-757
[43]   Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer [J].
Singer, S. ;
Ziegler, C. ;
Schwalenberg, T. ;
Hinz, A. ;
Goetze, H. ;
Schulte, T. .
SUPPORTIVE CARE IN CANCER, 2013, 21 (05) :1383-1393
[44]   Impact of bladder cancer on health-related quality of life [J].
Smith, Angela B. ;
Jaeger, Byron ;
Pinheiro, Laura C. ;
Edwards, Lloyd J. ;
Tan, Hung-Jui ;
Nielsen, Matthew E. ;
Reeve, Bryce B. .
BJU INTERNATIONAL, 2018, 121 (04) :549-557
[45]   The impact of BMI on quality of life in obese endometrial cancer survivors: Does size matter? [J].
Smits, Anke ;
Lopes, Alberto ;
Das, Nagindra ;
Bekkers, Ruud ;
Galaal, Khadra .
GYNECOLOGIC ONCOLOGY, 2014, 132 (01) :137-141
[46]   Quality of Life With Urinary Diversion [J].
Somani, Bhaskar K. ;
MacLennan, Sara Jane ;
N'Dow, James .
EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (10) :763-771
[47]  
Sprangers M.A.G., 2014, Encyclopedia of Quality of Life and Well-Being Research, DOI [DOI 10.1007/978-94-007-0753-5_901, 10.1007/978-94-007-0753-5_901]
[48]   THE SWEDISH SF-36 HEALTH SURVEY .1. EVALUATION OF DATA QUALITY, SCALING ASSUMPTIONS, RELIABILITY AND CONSTRUCT-VALIDITY ACROSS GENERAL POPULATIONS IN SWEDEN [J].
SULLIVAN, M ;
KARLSSON, J ;
WARE, JE .
SOCIAL SCIENCE & MEDICINE, 1995, 41 (10) :1349-1358
[49]   The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease [J].
Svatek, Robert S. ;
Hollenbeck, Brent K. ;
Holmang, Sten ;
Lee, Richard ;
Kim, Simon P. ;
Stenzl, Arnulf ;
Lotan, Yair .
EUROPEAN UROLOGY, 2014, 66 (02) :253-262
[50]   Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials [J].
Sylvester, RJ ;
van der Meijden, APM ;
Oosterlinck, W ;
Witjes, JA ;
Bouffioux, C ;
Denis, L ;
Newling, DWW ;
Kurth, K .
EUROPEAN UROLOGY, 2006, 49 (03) :466-477